Osaic Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Buy |
4,647
+4,541
| +4,284% | +$165K | ﹤0.01% | 3728 |
|
|
2025
Q1 | $3.84K | Sell |
106
-391
| -79% | -$14.2K | ﹤0.01% | 6205 |
|
|
2024
Q4 | $15.6K | Buy |
497
+170
| +52% | +$5.34K | ﹤0.01% | 5468 |
|
|
2024
Q3 | $18.2K | Sell |
327
-160
| -33% | -$8.89K | ﹤0.01% | 5392 |
|
|
2024
Q2 | $20K | Sell |
487
-317
| -39% | -$13K | ﹤0.01% | 5299 |
|
|
2024
Q1 | $37.5K | Sell |
804
-4,024
| -83% | -$188K | ﹤0.01% | 4922 |
|
|
2023
Q4 | $231K | Sell |
4,828
-2,591
| -35% | -$124K | ﹤0.01% | 3799 |
|
|
2023
Q3 | $264K | Sell |
7,419
-159
| -2% | -$5.67K | ﹤0.01% | 3785 |
|
|
2023
Q2 | $349K | Buy |
7,578
+1,982
| +35% | +$91.4K | ﹤0.01% | 3459 |
|
|
2023
Q1 | $224K | Buy |
5,596
+688
| +14% | +$27.5K | ﹤0.01% | 3778 |
|
|
2022
Q4 | $229K | Buy |
4,908
+1,018
| +26% | +$47.5K | ﹤0.01% | 3727 |
|
|
2022
Q3 | $162K | Buy |
3,890
+1,000
| +35% | +$41.6K | ﹤0.01% | 3942 |
|
|
2022
Q2 | $171K | Buy |
2,890
+75
| +3% | +$4.44K | ﹤0.01% | 3942 |
|
|
2022
Q1 | $198K | Sell |
2,815
-15
| -0.5% | -$1.06K | ﹤0.01% | 4039 |
|
|
2021
Q4 | $236K | Buy |
2,830
+1,218
| +76% | +$102K | ﹤0.01% | 3796 |
|
|
2021
Q3 | $146K | Buy |
1,612
+339
| +27% | +$30.7K | ﹤0.01% | 4204 |
|
|
2021
Q2 | $122K | Sell |
1,273
-1,401
| -52% | -$134K | ﹤0.01% | 4309 |
|
|
2021
Q1 | $306K | Buy |
2,674
+852
| +47% | +$97.5K | ﹤0.01% | 3358 |
|
|
2020
Q4 | $253K | Buy |
1,822
+248
| +16% | +$34.4K | ﹤0.01% | 3259 |
|
|
2020
Q3 | $128K | Buy |
1,574
+418
| +36% | +$34K | ﹤0.01% | 3613 |
|
|
2020
Q2 | $90K | Buy |
1,156
+197
| +21% | +$15.3K | ﹤0.01% | 3751 |
|
|
2020
Q1 | $43K | Buy |
+959
| New | +$43K | ﹤0.01% | 4061 |
|